About
Jerusalem Venture Partners (JVP) is an internationally recognized venture capital firm founded in 1993 by Dr. Erel Margalit. JVP has a strong presence in Israel (Jerusalem, Tel Aviv, Galilee, Be'er Sheva, Haifa) and New York, and focuses on early to growth-stage investments. The firm has raised over $1.4 billion across multiple funds and has a track record of successful exits, including IPOs on NASDAQ. JVP's investment strategy involves taking early, significant positions in companies and continuing to invest in follow-on rounds. They are known for their ecosystem-driven approach, fostering innovation through dedicated Centers of Excellence like Margalit Startup City. JVP invests in sectors such as cybersecurity, enterprise data & AI, FinTech, InsurTech, and ClimaTech.
Portfolio · 1
Investment activity
Portfolio by sector
Q&A
- What is JVC's primary investment focus by sector?
- JVC primarily focuses its investments within the Health Tech & Life Sciences sector, with all three of its portfolio companies operating in this area.
- Can you name some of JVC's notable portfolio companies?
- JVC's portfolio includes Magenta Medical, which has raised $224.9M, and Pharma Two B, which has raised $46.11M.
- What is JVC's investment stage preference?
- JVC has participated in various funding stages, including A Round, C Round, and E Round investments.
- What was JVC's most recent investment activity?
- JVC made an investment in July 2024, adding a new company to its portfolio.
- What is the typical investment range for JVC?
- JVC's investment range is between $2.7M and $105M.
- When did JVC make its earliest recorded investment?
- JVC's earliest recorded investment was in February 2017.
- What kind of investor is JVC?
- JVC is a corporate venture capital firm.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)
Identifiers & details
| Founded | 1993-1 |
|---|
Radar intelligence
Patents
| EPO | 7721 |
|---|
Publications (Crossref)
| Works | 10 |
|---|